Literature DB >> 27019113

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Takahiko Yasuda1,2, Shinobu Tsuzuki3, Masahito Kawazu4, Fumihiko Hayakawa2, Shinya Kojima1, Toshihide Ueno1, Naoto Imoto2, Shinji Kohsaka4, Akiko Kunita5, Koichiro Doi6, Toru Sakura7, Toshiaki Yujiri8, Eisei Kondo9, Katsumichi Fujimaki10, Yasunori Ueda11, Yasutaka Aoyama12, Shigeki Ohtake13, Junko Takita14, Eirin Sai4, Masafumi Taniwaki15, Mineo Kurokawa16, Shinichi Morishita6, Masashi Fukayama5, Hitoshi Kiyoi2, Yasushi Miyazaki17, Tomoki Naoe18, Hiroyuki Mano1.   

Abstract

The oncogenic mechanisms underlying acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA; 15-39 years old) remain largely elusive. Here we have searched for new oncogenes in AYA-ALL by performing RNA-seq analysis of Philadelphia chromosome (Ph)-negative AYA-ALL specimens (n = 73) with the use of a next-generation sequencer. Interestingly, insertion of D4Z4 repeats containing the DUX4 gene into the IGH locus was frequently identified in B cell AYA-ALL, leading to a high level of expression of DUX4 protein with an aberrant C terminus. A transplantation assay in mice demonstrated that expression of DUX4-IGH in pro-B cells was capable of generating B cell leukemia in vivo. DUX4 fusions were preferentially detected in the AYA generation. Our data thus show that DUX4 can become an oncogenic driver as a result of somatic chromosomal rearrangements and that AYA-ALL may be a clinical entity distinct from ALL at other ages.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27019113     DOI: 10.1038/ng.3535

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  26 in total

Review 1.  Restraining the V(D)J recombinase.

Authors:  David B Roth
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

2.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.

Authors:  Linda N Geng; Zizhen Yao; Lauren Snider; Abraham P Fong; Jennifer N Cech; Janet M Young; Silvere M van der Maarel; Walter L Ruzzo; Robert C Gentleman; Rabi Tawil; Stephen J Tapscott
Journal:  Dev Cell       Date:  2011-12-29       Impact factor: 12.270

3.  Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions.

Authors:  Anniek Corveleyn; Hilde Janssen; Alessandra Martini; Riet Somers; Jan Cools; Peter Marynen
Journal:  J Cell Biochem       Date:  2005-04-15       Impact factor: 4.429

Review 4.  Acute lymphoblastic leukemia in adolescents and young adults.

Authors:  Patrick W Burke; Dan Douer
Journal:  Acta Haematol       Date:  2014-09-10       Impact factor: 2.195

5.  Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.

Authors:  Takako Iida Jones; Jennifer C J Chen; Fedik Rahimov; Sachiko Homma; Patricia Arashiro; Mary Lou Beermann; Oliver D King; Jeffrey B Miller; Louis M Kunkel; Charles P Emerson; Kathryn R Wagner; Peter L Jones
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

6.  TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice.

Authors:  Shinobu Tsuzuki; Masao Seto
Journal:  Stem Cells       Date:  2013-02       Impact factor: 6.277

7.  IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome.

Authors:  Lisa J Russell; Amir Enshaei; Lisa Jones; Amy Erhorn; Dino Masic; Helen Bentley; Karl S Laczko; Adele K Fielding; Anthony H Goldstone; Nicholas Goulden; Christopher D Mitchell; Rachel Wade; Ajay Vora; Anthony V Moorman; Christine J Harrison
Journal:  J Clin Oncol       Date:  2014-04-07       Impact factor: 44.544

8.  Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.

Authors:  Lauren Snider; Linda N Geng; Richard J L F Lemmers; Michael Kyba; Carol B Ware; Angelique M Nelson; Rabi Tawil; Galina N Filippova; Silvère M van der Maarel; Stephen J Tapscott; Daniel G Miller
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

9.  deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.

Authors:  Andrew McPherson; Fereydoun Hormozdiari; Abdalnasser Zayed; Ryan Giuliany; Gavin Ha; Mark G F Sun; Malachi Griffith; Alireza Heravi Moussavi; Janine Senz; Nataliya Melnyk; Marina Pacheco; Marco A Marra; Martin Hirst; Torsten O Nielsen; S Cenk Sahinalp; David Huntsman; Sohrab P Shah
Journal:  PLoS Comput Biol       Date:  2011-05-19       Impact factor: 4.475

10.  Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.

Authors:  F Hayakawa; T Sakura; T Yujiri; E Kondo; K Fujimaki; O Sasaki; J Miyatake; H Handa; Y Ueda; Y Aoyama; S Takada; Y Tanaka; N Usui; S Miyawaki; S Suenobu; K Horibe; H Kiyoi; K Ohnishi; Y Miyazaki; S Ohtake; Y Kobayashi; K Matsuo; T Naoe
Journal:  Blood Cancer J       Date:  2014-10-17       Impact factor: 11.037

View more
  88 in total

1.  CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma.

Authors:  Toyoki Yoshimoto; Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Yutaka Takazawa; Cristina R Antonescu; Takuro Nakamura
Journal:  Cancer Res       Date:  2017-04-12       Impact factor: 12.701

Review 2.  Genetics and prognosis of ALL in children vs adults.

Authors:  Kathryn G Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Corrigendum: Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Authors:  Takahiko Yasuda; Shinobu Tsuzuki; Masahito Kawazu; Fumihiko Hayakawa; Shinya Kojima; Toshihide Ueno; Naoto Imoto; Shinji Kohsaka; Akiko Kunita; Koichiro Doi; Toru Sakura; Toshiaki Yujiri; Eisei Kondo; Katsumichi Fujimaki; Yasunori Ueda; Yasutaka Aoyama; Shigeki Ohtake; Junko Takita; Eirin Sai; Masafumi Taniwaki; Mineo Kurokawa; Shinichi Morishita; Masashi Fukayama; Hitoshi Kiyoi; Yasushi Miyazaki; Tomoki Naoe; Hiroyuki Mano
Journal:  Nat Genet       Date:  2016-11-29       Impact factor: 38.330

4.  Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.

Authors:  Jinghui Zhang; Kelly McCastlain; Hiroki Yoshihara; Beisi Xu; Yunchao Chang; Michelle L Churchman; Gang Wu; Yongjin Li; Lei Wei; Ilaria Iacobucci; Yu Liu; Chunxu Qu; Ji Wen; Michael Edmonson; Debbie Payne-Turner; Kerstin B Kaufmann; Shin-Ichiro Takayanagi; Erno Wienholds; Esmé Waanders; Panagiotis Ntziachristos; Sofia Bakogianni; Jingjing Wang; Iannis Aifantis; Kathryn G Roberts; Jing Ma; Guangchun Song; John Easton; Heather L Mulder; Xiang Chen; Scott Newman; Xiaotu Ma; Michael Rusch; Pankaj Gupta; Kristy Boggs; Bhavin Vadodaria; James Dalton; Yanling Liu; Marcus L Valentine; Li Ding; Charles Lu; Robert S Fulton; Lucinda Fulton; Yashodhan Tabib; Kerri Ochoa; Meenakshi Devidas; Deqing Pei; Cheng Cheng; Jun Yang; William E Evans; Mary V Relling; Ching-Hon Pui; Sima Jeha; Richard C Harvey; I-Ming L Chen; Cheryl L Willman; Guido Marcucci; Clara D Bloomfield; Jessica Kohlschmidt; Krzysztof Mrózek; Elisabeth Paietta; Martin S Tallman; Wendy Stock; Matthew C Foster; Janis Racevskis; Jacob M Rowe; Selina Luger; Steven M Kornblau; Sheila A Shurtleff; Susana C Raimondi; Elaine R Mardis; Richard K Wilson; John E Dick; Stephen P Hunger; Mignon L Loh; James R Downing; Charles G Mullighan
Journal:  Nat Genet       Date:  2016-10-24       Impact factor: 38.330

5.  Transcriptional activities of DUX4 fusions in B-cell acute lymphoblastic leukemia.

Authors:  Yosuke Tanaka; Masahito Kawazu; Takahiko Yasuda; Miki Tamura; Fumihiko Hayakawa; Shinya Kojima; Toshihide Ueno; Hitoshi Kiyoi; Tomoki Naoe; Hiroyuki Mano
Journal:  Haematologica       Date:  2018-05-17       Impact factor: 9.941

6.  Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.

Authors:  Jian-Feng Li; Yu-Ting Dai; Henrik Lilljebjörn; Shu-Hong Shen; Bo-Wen Cui; Ling Bai; Yuan-Fang Liu; Mao-Xiang Qian; Yasuo Kubota; Hitoshi Kiyoi; Itaru Matsumura; Yasushi Miyazaki; Linda Olsson; Ah Moy Tan; Hany Ariffin; Jing Chen; Junko Takita; Takahiko Yasuda; Hiroyuki Mano; Bertil Johansson; Jun J Yang; Allen Eng-Juh Yeoh; Fumihiko Hayakawa; Zhu Chen; Ching-Hon Pui; Thoas Fioretos; Sai-Juan Chen; Jin-Yan Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-28       Impact factor: 11.205

7.  CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Ester Mejstrikova; Angela Schumich; Marketa Zaliova; Klaus Fortschegger; Karin Nebral; Andishe Attarbaschi; Karel Fiser; Maximilian O Kauer; Niko Popitsch; Sabrina Haslinger; Andrea Inthal; Barbara Buldini; Giuseppe Basso; Jean-Pierre Bourquin; Giuseppe Gaipa; Monika Brüggemann; Tamar Feuerstein; Margarita Maurer-Granofszky; Renate Panzer-Grümayer; Jan Trka; Georg Mann; Oskar A Haas; Ondrej Hrusak; Michael N Dworzak; Sabine Strehl
Journal:  Haematologica       Date:  2019-01-31       Impact factor: 9.941

Review 8.  Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.

Authors:  Jianfeng Li; Yuting Dai; Liang Wu; Ming Zhang; Wen Ouyang; Jinyan Huang; Saijuan Chen
Journal:  Front Med       Date:  2021-01-05       Impact factor: 4.592

Review 9.  How advanced are we in targeting novel subtypes of ALL?

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2019-10-18       Impact factor: 3.020

10.  PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors:  Zhaohui Gu; Michelle L Churchman; Kathryn G Roberts; Ian Moore; Xin Zhou; Joy Nakitandwe; Kohei Hagiwara; Stephane Pelletier; Sebastien Gingras; Hartmut Berns; Debbie Payne-Turner; Ashley Hill; Ilaria Iacobucci; Lei Shi; Stanley Pounds; Cheng Cheng; Deqing Pei; Chunxu Qu; Scott Newman; Meenakshi Devidas; Yunfeng Dai; Shalini C Reshmi; Julie Gastier-Foster; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Alessandro Rambaldi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Janis Racevskis; Yanming Zhang; Ravi Bhatia; Jessica Kohlschmidt; Krzysztof Mrózek; Clara D Bloomfield; Wendy Stock; Steven Kornblau; Hagop M Kantarjian; Marina Konopleva; Williams E Evans; Sima Jeha; Ching-Hon Pui; Jun Yang; Elisabeth Paietta; James R Downing; Mary V Relling; Jinghui Zhang; Mignon L Loh; Stephen P Hunger; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.